Want to see DERM full AI Analyst Report?
Journey Medical Corp (DERM) Stock Statistics & Valuation Metrics
Total Valuation
Journey Medical Corp has a market cap or net worth of $145.92M. The enterprise value is $194.55M.
- Market Cap
- $145.92M
- Enterprise Value
- $194.55M
Share Statistics
Journey Medical Corp has 22,224,396 shares outstanding. The number of shares has decreased by -2.65% in one year.
- Shares Outstanding
- 22,224,396
- Owned by Insiders
- 19.48%
- Owned by Institutions
- 28.48%
Financial Efficiency
Journey Medical Corp’s return on equity (ROE) is -0.36 and return on invested capital (ROIC) is -14.27%.
- Return on Equity (ROE)
- -0.36
- Return on Assets (ROA)
- -0.12
- Return on Invested Capital (ROIC)
- -14.27%
- Return on Capital Employed (ROCE)
- -0.14
- Revenue Per Employee
- 1.07M
- Profits Per Employee
- -197.09K
- Employee Count
- 58
- Asset Turnover
- 0.65
- Inventory Turnover
- 2.62
Valuation Ratios
The current PE Ratio of Journey Medical Corp is -22.89. Journey Medical Corp’s PEG ratio is -1.09.
- PE Ratio
- -22.89
- PS Ratio
- 2.14
- PB Ratio
- 4.43
- Price to FCF
- -19.48
- Price to Operating Cash Flow
- -18.97
- PEG Ratio
- -1.09
Income Statement
In the last 12 months, Journey Medical Corp had revenue of 61.86M and earned -11.43M in profits. Earnings per share was -0.47.
- Revenue
- 61.86M
- Gross Profit
- 36.68M
- Operating Income
- -8.17M
- Pretax Income
- -11.37M
- Net Income
- -11.43M
- EBITDA
- -3.33M
- Earnings Per Share (EPS)
- -0.47
Cash Flow
In the last 12 months, operating cash flow was -7.49M and capital expenditures 0, giving a free cash flow of -7.49M billion.
- Operating Cash Flow
- -7.49M
- Free Cash Flow
- -7.49M
- Free Cash Flow per Share
- -0.27
Dividends & Yields
Journey Medical Corp pays an annual dividend of ―, resulting in a dividend yield of ―
- Dividend Per Share
- ―
- Dividend Yield
- ―
- Payout Ratio
- N/A
- Free Cash Flow Yield
- -5.13%
- Earnings Yield
- -4.29%
Stock Price Statistics
- Beta
- 0.40
- 52-Week Price Change
- -37.79%
- 50-Day Moving Average
- 6.52
- 200-Day Moving Average
- 6.61
- Relative Strength Index (RSI)
- 40.50
- Average Volume (3m)
- 200.05K
Important Dates
Journey Medical Corp upcoming earnings date is Nov 11, 2026, TBA (Not Confirmed).
- Last Earnings Date
- Aug 12, 2026
- Next Earnings Date
- Nov 11, 2026
- Ex-Dividend Date
- ―
Financial Position
Journey Medical Corp as a current ratio of 1.79, with Debt / Equity ratio of 79.73%
- Current Ratio
- 1.79
- Quick Ratio
- 1.53
- Debt to Market Cap
- 0.13
- Net Debt to EBITDA
- -0.39
- Interest Coverage Ratio
- -2.21
Taxes
In the past 12 months, Journey Medical Corp has paid 60.00K in taxes.
- Income Tax
- 60.00K
- Effective Tax Rate
- -0.01
Enterprise Valuation
Journey Medical Corp EV to EBITDA ratio is 77.94, with an EV/FCF ratio of -19.46.
- EV to Sales
- 2.14
- EV to EBITDA
- 77.94
- EV to Free Cash Flow
- -19.46
- EV to Operating Cash Flow
- -19.46
Balance Sheet
Journey Medical Corp has $25.64M in cash and marketable securities with $25.54M in debt, giving a net cash position of $102.00K billion.
- Cash & Marketable Securities
- $25.64M
- Total Debt
- $25.54M
- Net Cash
- $102.00K
- Net Cash Per Share
- $0.00
- Tangible Book Value Per Share
- $0.24
Margins
Gross margin is 62.24%, with operating margin of -4.41%, and net profit margin of -8.95%.
- Gross Margin
- 62.24%
- Operating Margin
- -4.41%
- Pretax Margin
- -8.93%
- Net Profit Margin
- -8.95%
- EBITDA Margin
- 2.74%
- EBIT Margin
- -3.55%
Analyst Forecast
The average price target for Journey Medical Corp is $13.50, which is 11.43% higher than the current price. The consensus rating is Moderate Buy
- Price Target
- $13.50
- Price Target Upside
- 161.12% Upside
- Analyst Consensus
- Moderate Buy
- Analyst Count
- 2
- Revenue Growth Forecast
- 20.89%
- EPS Growth Forecast
- 40.71%
Scores
- Smart Score
- 5
- AI Score
- 53
